FDA meeting on September 20-21, 2016

Posted in Latest News on September 23, 2016.

pharmacy-pic2

On September 20-21, 2016 Allison Dudley, Executive Director and David Flynn, Counsel to the Board attended an inter-governmental working meeting at the Food and Drug Administration to discuss the oversight of drug compounding and the relationship between the activities of the FDA and the states. The meeting provided an opportunity to discuss each state’s regulatory framework, recent FDA guidance documents, changes to the FDA’s inspection procedures, and information sharing challenges and opportunities.



More Latest News

First Quarter Performance Report
December 29, 2020

Released for Fiscal Year
2020-2021
Continue reading


Notification of Renewal Deadline Extension
December 29, 2020

State Surgeon General Scott A. Rivkees issued Emergency Order 20-015 granting licensure renewal extensions Continue reading